Infection after primary hip arthroplasty: a comparison of 3 Norwegian health registers

Background and purpose

The aim of the present study was to assess incidence of and risk factors for infection after hip arthroplasty in data from 3 national health registries. We investigated differences in risk patterns between surgical site infection (SSI) and revision due to infection after primary total hip arthroplasty (THA) and hemiarthroplasty (HA).

Materials and methods

This observational study was based on prospective data from 2005–2009 on primary THAs and HAs from the Norwegian Arthroplasty Register (NAR), the Norwegian Hip Fracture Register (NHFR), and the Norwegian Surveillance System for Healthcare–Associated Infections (NOIS). The Norwegian Patient Register (NPR) was used for evaluation of case reporting. Cox regression analyses were performed with revision due to infection as endpoint for data from the NAR and the NHFR, and with SSI as the endpoint for data from the NOIS.

Results

The 1–year incidence of SSI in the NOIS was 3.0% after THA (167/5,540) and 7.3% after HA (103/1,416). The 1–year incidence of revision due to infection was 0.7% for THAs in the NAR (182/24,512) and 1.5% for HAs in the NHFR (128/8,262). Risk factors for SSI after THA were advanced age, ASA class higher than 2, and short duration of surgery. For THA, the risk factors for revision due to infection were male sex, advanced age, ASA class higher than 1, emergency surgery, uncemented fixation, and a National Nosocomial Infection Surveillance (NNIS) risk index of 2 or more. For HAs inserted after fracture, age less than 60 and short duration of surgery were risk factors of revision due to infection.

Interpretation

The incidences of SSI and revision due to infection after primary hip replacements in Norway are similar to those in other countries. There may be differences in risk pattern between SSI and revision due to infection after arthroplasty. The risk patterns for revision due to infection appear to be different for HA and THA.Increasing incidence of revision due to infection after primary total hip arthroplasty (THA) has been observed in different countries during the last decade (Kurtz et al. 2008, Dale et al. 2009, Pedersen et al. 2010). There have been several studies on incidence of and risk factors for infection based on data from surveillance systems (Ridgeway et al. 2005, Mannien et al. 2008), arthroplasty (quality) registers (Berbari et al. 1998, Dale et al. 2009, Pedersen et al. 2010), and administrative databases (Mahomed et al. 2003, Kurtz et al. 2008, Ong et al. 2009). There have been reviews on incidence of and risk factors for infection after hip arthroplasty, based on publications from databases with different definitions of infection (Urquhart et al. 2009, Jämsen et al. 2010a). Superficial surgical site infections (SSIs) may have risk factors that are different from those of full surgical revisions due to infection. Furthermore, THA and hip hemiarthroplasty (HA) may have different patterns of risk of infection (Ridgeway et al. 2005, Cordero–Ampuero and de Dios 2010).In the present study, we used data from 3 national health registries in Norway to assess incidence and some risk factors for infection after primary hip arthroplasty. Differences in risk patterns between SSI and revision due to infection were investigated for HA and THA.     

Role of preoperative pain,muscle function,and activity level in discharge readiness after fast-track hip and knee arthroplasty

Methods Before surgery, hip pain (THA) or knee pain (TKA), lower-extremity muscle power, functional performance, and physical activity were assessed in a sample of 150 patients and used as independent variables to predict the outcome (dependent variable)—readiness for hospital discharge —for each type of surgery. Discharge readiness was assessed twice daily by blinded assessors.Results Median discharge readiness and actual length of stay until discharge were both 2 days. Univariate linear regression followed by multiple linear regression revealed that age was the only independent predictor of discharge readiness in THA and TKA, but the standardized coefficients were small (≤ 0.03).Interpretation These results support the idea that fast-track THA and TKA with a length of stay of about 2–4 days can be achieved for most patients independently of preoperative functional characteristics.Over the last decade, length of stay (LOS) with discharge to home after primary THA and TKA has declined from about 5–10 days to about 2–4 days in selected series and larger nationwide series (Malviya et al. 2011, Raphael et al. 2011, Husted et al. 2012, Kehlet 2013, Hartog et al. 2013, Jørgensen and Kehlet 2013). However, there is a continuing debate about whether selected patients only or all patients should be scheduled for “fast-track” THA and TKA in relation to psychosocial factors and preoperative pain and functional status (Schneider et al. 2009, Hollowell et al. 2010, Macdonald et al. 2010, Antrobus and Bryson 2011, Jørgensen and Kehlet 2013), or whether organizational or pathophysiological factors in relation to the surgical trauma may determine the length of stay (Husted et al. 2011, Husted 2012).We studied the role of THA and TKA patients’ preoperative pain and functional characteristics in discharge from 2 orthopedic departments with well-established fast-track recovery regimens (Husted et al. 2010).     

High-volume infiltration analgesia in bilateral hip arthroplasty. A randomized, double-blind placebo-controlled trial

Background and purpose

High-volume infiltration analgesia may be effective in postoperative pain management after hip arthroplasty but methodological problems prevent exact interpretation of previous studies.

Methods

In a randomized, double-blind placebo-controlled trial in 12 patients undergoing bilateral total hip arthroplasty (THA) in a fast-track setting, saline or high-volume (170 mL) ropivacaine (0.2%) with epinephrine (1:100,000) was administered to the wound intraoperatively along with supplementary postoperative injections via an intraarticular epidural catheter. Oral analgesia was instituted preoperatively with a multimodal regimen (gabapentin, celecoxib, and acetaminophen). Pain was assessed repeatedly for 48 hours postoperatively, at rest and with 45° hip flexion.

Results

Pain scores were low and similar between ropivacaine and saline administration. Median hospital stay was 4 (range 2–7) days.

Interpretation

Intraoperative high-volume infiltration with 0.2% ropivacaine with repeated intraarticular injections postoperatively may not give a clinically relevant analgesic effect in THA when combined with a multimodal oral analgesic regimen with gabapentin, celecoxib, and acetaminophen.Continuous epidural analgesia (Choi et al. 2003) or continuous or single-shot peripheral nerve blocks (Boezaart 2006, Ilfeld et al. 2008) may provide sufficient analgesia after total hip arthroplasty (THA), but both techniques are associated with potential motor blockade, thereby hindering early rehabilitation (Choi et al 2003, Boezaart 2006, Ilfeld et al. 2008).Local infiltration analgesia (LIA) (Röstlund and Kehlet 2007, Kerr and Kohan 2008, Otte et al. 2008) with intraoperative infiltration of local anesthetic in the surgical wound and subsequent supplementary postoperative intraarticular or wound injections has been reported to be effective in knee arthroplasty (Andersen et al. 2008). However, for THA only limited and inconclusive data are available from placebo-controlled and randomized trials (Bianconi et al. 2003, Andersen et al. 2007 a, b, Busch et al. 2010) and from non-randomized cohort studies (Kerr and Kohan 2008, Otte et al. 2008). We therefore decided to evaluate the analgesic efficacy of LIA in a placebo-controlled, randomized and double-blind trial in fast-track bilateral hip arthroplasty with administration of either ropivacaine or saline to the wound, thereby limiting the large inter-individual pain response to THA. This design has proven valid in assessing the analgesic value of LIA in TKA (Andersen et al. 2008). The primary endpoint was pain on flexion of the hip joint 8 hours postoperatively.     

Perioperative mortality after hemiarthroplasty related to fixation method

Background and purpose

The appropriate fixation method for hemiarthroplasty of the hip as it relates to implant survivorship and patient mortality is a matter of ongoing debate. We examined the influence of fixation method on revision rate and mortality.

Methods

We analyzed approximately 25,000 hemiarthroplasty cases from the AOA National Joint Replacement Registry. Deaths at 1 day, 1 week, 1 month, and 1 year were compared for all patients and among subgroups based on implant type.

Results

Patients treated with cemented monoblock hemiarthroplasty had a 1.7-times higher day-1 mortality compared to uncemented monoblock components (p < 0.001). This finding was reversed by 1 week, 1 month, and 1 year after surgery (p < 0.001). Modular hemiarthroplasties did not reveal a difference in mortality between fixation methods at any time point.

Interpretation

This study shows lower (or similar) overall mortality with cemented hemiarthroplasty of the hip.The frequency of hip fractures is increasing with our ageing population, with an annual incidence of between 1.4 and 5 per 103 per year (Lonnroos et al. 2006, Icks et al. 2008, Varez-Nebreda et al. 2008). Health model projections have estimated that 6.3 million hip fractures will occur annually worldwide within the next 40 years (Cooper et al. 1992), imposing a significant economic health burden. There is a large reported perioperative mortality rate in this population, ranging from 2.4% to 8.2% at 1 month (Parvizi et al. 2001, Radcliff et al. 2008) and over 25% at 1 year (Elliott et al. 2003, Jiang et al. 2005). Furthermore, it was recently reported that the current mortality rate is higher now than 25 years ago (Vestergaard et al. 2007a). Today, it is generally accepted that displaced intracapsular fractures are best treated with arthroplasty rather than internal fixation (Keating et al. 2006, Leighton et al. 2007). In the at-risk population, however, multiple comorbidities are common and the best form of component fixation is in question.Bone cement implantation syndrome is a well-described complication of cemented hip arthroplasty. It is characterized by a systemic drop in systolic blood pressure, hypoxemia, pulmonary hypertension, cardiac dysrhythmias, and occasionally cardiac arrest and death (Rinecker 1980, Orsini et al. 1987, Parvizi et al. 1999). The prevailing theory to explain the pathophysiology of this phenomenon is embolism of fat, marrow contents, bone, and to some degree methylmethacrylate to the lung (Rinecker 1980, Elmaraghy et al. 1998, Parvizi et al. 1999, Koessler et al. 2001). An increased degree of pulmonary insult with fat microemboli has been demonstrated (mostly in randomized controlled trials) during insertion of a cemented femoral stem rather than an uncemented implant (Orsini et al. 1987, Ries et al. 1993, Christie et al. 1994, Pitto et al. 1999), presumably due to increased intramedullary femoral canal pressures in the cemented group (Kallos et al. 1974, Orsini et al. 1987). These pressures can be reduced by the use of distal venting holes in the femur during stem insertion (Engesæter et al. 1984). It has been shown previously by single-institutional review that patients undergoing cemented hip arthroplasty have a higher intraoperative mortality rate relative to uncemented arthroplasty, presumably due to a reduced incidence of fat embolism in the latter group (Parvizi et al. 1999). The increased mortality risk was also present at 30 days in the treatment of acute fractures with cemented arthroplasty, also from a single-institutional review (Parvizi et al. 2004). Although cement-related mortality is rare (Dearborn and Harris 1998, Parvizi et al. 1999, 2001, 2004, Weinrauch et al. 2006), it is a devastating complication—often reported through observational studies or literature reviews. Proponents of uncemented hip arthroplasty often cite this concern to support their reluctance to use cemented hip arthroplasty in both elective procedures and fracture management. However, many different types of studies have been unable to identify any increased mortality risk with the use of cement (Lausten and Vedel 1982 (observational), Emery et al. 1991 (RCT), Lo et al. 1994 (observational), Khan et al. 2002a,b (literature review), Parker and Gurusamy 2004 (literature review)) and others have shown a decrease in mortality at 30 days when cement is used (Foster et al. 2005).Cemented hip hemiarthroplasty appears to offer improved rate of return to baseline function, reduced postoperative pain, and superior long-term survivorship relative to uncemented arthroplasty (Khan et al. 2002a, b, Parker and Gurusamy 2004). We reasoned that failure to return to baseline function after hemiarthroplasty may be another risk factor for perioperative mortality (Hannan et al. 2001, Braithwaite et al. 2003). Lower revision rates for cemented prostheses and increased mortality at revision surgery contribute further to reducing the overall mortality risk. We evaluated the relationship between the method of fixation of hip arthroplasty and perioperative mortality using a large national joint replacement registry.     

Why still in hospital after fast-track hip and knee arthroplasty?

Background and purpose

Length of stay (LOS) following total hip and knee arthroplasty (THA and TKA) has been reduced to about 3 days in fast-track setups with functional discharge criteria. Earlier studies have identified patient characteristics predicting LOS, but little is known about specific reasons for being hospitalized following fast-track THA and TKA.

Patients and methods

To determine clinical and logistical factors that keep patients in hospital for the first postoperative 24–72 hours, we performed a cohort study of consecutive, unselected patients undergoing unilateral primary THA (n = 98) or TKA (n = 109). Median length of stay was 2 days. Patients were operated with spinal anesthesia and received multimodal analgesia with paracetamol, a COX-2 inhibitor, and gabapentin—with opioid only on request. Fulfillment of functional discharge criteria was assessed twice daily and specified reasons for not allowing discharge were registered.

Results

Pain, dizziness, and general weakness were the main clinical reasons for being hospitalized at 24 and 48 hours postoperatively while nausea, vomiting, confusion, and sedation delayed discharge to a minimal extent. Waiting for blood transfusion (when needed), for start of physiotherapy, and for postoperative radiographic examination delayed discharge in one fifth of the patients.

Interpretation

Future efforts to enhance recovery and reduce length of stay after THA and TKA should focus on analgesia, prevention of orthostatism, and rapid recovery of muscle function.Total hip and total knee arthroplasty (THA and TKA) are frequent operations with an average length of stay (LOS) of about 6–12 days in the United Kingdom, Germany, and Denmark (Husted et al. 2006, Bundesauswertung 2009, NHS 2010).During the last decade, however, there has been increased interest in optimal multimodal perioperative care to enhance recovery (the fast-track methodology). Improvement of analgesia; reduction of surgical stress responses and organ dysfunctions including nausea, vomiting, and ileus; early mobilization; and oral nutrition have been of particular interest (Kehlet 2008, Kehlet and Wilmore 2008). These principles have also been applied to THA and TKA, resulting in improvements in pain treatment with multimodal opioid-sparing regimens including a local anesthetic infiltration technique (LIA) or peripheral nerve blocks to facilitate early mobilization (Ilfeld et al. 2006a, b, 2010a, Andersen et al. 2008, Kerr and Kohan 2008), and allowing functional rehabilitation to be initiated a few hours postoperatively (Holm et al. 2010)—ultimately leading to a reduction in LOS (Husted et al. 2008, Barbieri et al. 2009, Husted et al. 2010a, b). Using these evidence-based regimens combined with an improved logistical setup, LOS is reduced to about 2–4 days (Kerr and Kohan 2008, Husted et al. 2010 a,b,c, Lunn et al. 2011).Having well-defined functional discharge criteria is imperative in order to ensure a safe discharge—and it is mandatory if meaningful comparison of LOS is done following alterations in the track (Husted et al. 2008). In the same fast-track setting, an earlier study focused on patient characteristics predicting LOS (Husted et al. 2008). However, little is known about the specific reasons for why patients are hospitalized during the first 1–3 days after THA or TKA; i.e. why can patients not be discharged?We therefore analyzed clinical and organizational factors responsible for being hospitalized in a well-defined prospective setup in a fast-track unit. This unit had previously documented LOS of about 2–3 days (Andersen et al. 2008, Holm et al. 2010, Husted et al. 2010b, c, Lunn et al. 2011).     

Removal of restrictions following primary THA with posterolateral approach does not increase the risk of early dislocation

Background and purpose

Patient education and mobilization restrictions are often used in an attempt to reduce the risk of dislocation following primary THA. To date, there have been no studies investigating the safety of removal of mobilization restrictions following THA performed using a posterolateral approach. In this retrospective non-inferiority study, we investigated the rate of early dislocation following primary THA in an unselected patient cohort before and after removal of postoperative mobilization restrictions.

Patients and methods

From the Danish National Health Registry, we identified patients with early dislocation in 2 consecutive and unselected cohorts of patients who received primary THA at our institution from 2004 through 2008 (n = 946) and from 2010 through 2014 (n = 1,329). Patients in the first cohort were mobilized with functional restrictions following primary THA whereas patients in the second cohort were allowed unrestricted mobilization. Risk of early dislocation (within 90 days) was compared in the 2 groups and odds ratio (OR)—adjusted for possible confounders—was calculated. Reasons for early dislocation in the 2 groups were identified.

Results

When we adjusted for potential confounders, we found no increased risk of early dislocation within 90 days in patients who were mobilized without restrictions. Risk of dislocation within 90 days was lower (3.4% vs 2.8%), risk of dislocation within 30 days was lower (2.1% vs 2.0%), and risk of multiple dislocations (1.8% vs 1.1%) was lower in patients who were mobilized without restrictions, but not statistically significantly so. Increasing age was an independent risk factor for dislocation.

Interpretation

Removal of mobilization restrictions from the mobilization protocol following primary THA performed with a posterolateral approach did not lead to an increased risk of dislocation within 90 days.Dislocation of the hip is one of the most common complications following total hip arthroplasty (THA), with reported incidence rates ranging from less than 1% to over 15%, and higher risk of dislocation after revision arthroplasty than after primary THA (Woo and Morrey 1982, Phillips et al. 2003, Khatod et al. 2006, Patel et al. 2007). Several patient-related and surgery-related parameters, such as age (Ali Khan et al. 1981), cognitive function (Fackler and Poss 1980, Jolles et al. 2002), component malposition (Lewinnek et al. 1978, Jolles et al. 2002, Nishii et al. 2004), surgical approach (Masonis and Bourne 2002) and soft-tissue related factors (White et al. 2001) contribute to the risk of dislocation. In the past, many surgeons have used patient education and postoperative mobilization restrictions in an attempt to reduce this risk (Woo and Morrey 1982, Morrey 1992, 1997). However, in recent years some authors have questioned the benefit of such restrictions (Peak et al. 2005, Restrepo et al. 2011) and no published studies have ever confirmed a reduction in dislocation using restrictions, making some authors question the value of postoperative restrictions (Husted et al. 2014).A possible limitation of these studies was that they all investigated primary THA performed using the anterolateral approach, which is probably associated with a lower rate of dislocation than primary THA using the posterior approach (Masonis and Bourne 2002). One recent study investigated a reduction in movement restrictions following primary THA with the posterolateral approach and found that fewer movement restrictions did not affect the patient-reported outcomes after 6 weeks, and led to earlier return to work. However, no recommendations on safety issues could be made due to the low number of patients (Mikkelsen et al. 2014).The main aim of this retrospective, non-inferiority study was to investigate the rate of early dislocation (within 90 days) following primary THA in an unselected patient cohort before and after removal of postoperative mobilization restrictions. We also investigated the reasons for dislocation in patients who were mobilized with and without restrictions.     

Risk factors for revision due to infection after primary total hip arthroplasty: A population-based study of 80,756 primary procedures in the Danish Hip Arthroplasty Registry

Background and purpose

There has been a limited amount of research on risk factors for revision due to infection following total hip arthroplasty (THA), probably due to low absolute numbers of revisions. We therefore studied patient- and surgery-related risk factors for revision due to infection after primary THA in a population-based setting.

Materials and methods

Using the Danish Hip Arthroplasty Registry, we identified 80,756 primary THAs performed in Denmark between Jan 1, 1995 and Dec 31, 2008. We used Cox regression analysis to compute crude and adjusted relative risk (RR) of revision due to infection. Revision was defined as extraction or exchange of any component due to infection. The median follow-up time was 5 (0–14) years.

Results

597 primary THAs (0.7%) were revised due to infection. Males, patients with any co-morbidity, patients operated due to non-traumatic avascular femoral head necrosis, and patients with long duration of surgery had an increased RR of revision due to infection within the total follow-up time. A tendency of increased RR of revision was found for patients who had received cemented THA without antibiotic and hybrid THA relative to patients with cementless implants. Hip diagnosis and fixation technique were not associated with risk of revision due to infection within 1 year of surgery (short-term risk).

Interpretation

We identified several categories of THA patients who had a higher risk of revision due to infection. Further research is required to explain the mechanism underlying this increased risk. More attention should be paid by clinicians to infection prevention strategies in patients with THA, particularly those with increased risk.As with any other surgical operation, serious complications in patients undergoing total hip arthroplasty (THA) include infections. Most infections stem either from contamination in the operating room or from later hematogenous spread. Deep infection is the third most common cause of revision of THAs in Denmark (DHR Annual repport 2008). In the last 2 decades, advances in theater design and the prophylactic use of antibiotics, either systemically or incorporated in cement, have substantially reduced the incidence of infection after hip replacement (Zimmerli and Ochsner 2003, Ridgeway et al. 2005, Phillips et al. 2006). However, recent studies in the United States and Norway have found increasing infection rates (Dale et al. 2009, Kurtz et al. 2010).Research on risk factors for revision due to infection following THA has been limited, probably due to low absolute numbers of revisions. However, in the last few years several reports have suggested that some patient- and surgery-related factors may play a role (Furnes et al. 2001, Saleh et al. 2002, Ridgeway et al. 2005, Engesaeter et al. 2006, Bongartz et al. 2008, Pulido et al. 2008, Dale et al. 2009, Hooper et al. 2009, Ong et al. 2009). Comparison of these studies is difficult due to different inclusion criteria for the study population and different definitions of infection, sometimes including both joint infections and superficial infections, or infections in general. We studied only the infections that were followed by revision of the implant.For this reason, we conducted a nationwide follow-up study using the Danish Hip Arthroplasty Registry to examine potential patient- and surgery-related risk factors for revision due to infection.     

Cancer incidence and cause-specific mortality in patients with metal-on-metal hip replacements in Finland: A population-based study with a mean follow-up of 4.6 (1–11) years

Background and purpose

Metal-on-metal hip implants have been widely used, especially in the USA, Australia, England and Wales, and Finland. We assessed risk of death and updated data on the risk of cancer related to metal-on-metal hip replacements.

Patients and methods

A cohort of 10,728 metal-on-metal hip replacement patients and a reference cohort of 18,235 conventional total hip replacement patients were extracted from the Finnish Arthroplasty Register for the years 2001–2010. Data on incident cancer cases and causes of death until 2011 were obtained from the Finnish Cancer Registry and Statistics Finland. The relative risk of cancer and death were expressed as standardized incidence ratio (SIR) and standardized mortality ratio (SMR). SIR/SIR ratios and SMR/SMR ratios, and Poisson regression were used to compare the cancer risk and the risk of death between cohorts.

Results

The overall risk of cancer in the metal-on-metal cohort was not higher than that in the non-metal-on-metal cohort (RR = 0.91, 95% CI: 0.82–1.02). The risk of soft-tissue sarcoma and basalioma in the metal-on-metal cohort was higher than in the non-metal-on-metal cohort (SIR/SIR ratio = 2.6, CI: 1.02–6.4 for soft-tissue sarcoma; SIR/SIR ratio = 1.3, CI: 1.1–1.5 for basalioma). The overall risk of death in the metal-on-metal cohort was less than that in the non-metal-on-metal cohort (RR = 0.78, CI: 0.69–0.88).

Interpretation

The overall risk of cancer or risk of death because of cancer is not increased after metal-on-metal hip replacement. The well-patient effect and selection bias contribute substantially to the findings concerning mortality. Arthrocobaltism does not increase mortality in patients with metal-on-metal hip implants in the short term. However, metal-on-metal hip implants should not be considered safe until data with longer follow-up time are available.Metal-on-metal hip implants have been widely used, especially in the USA, Australia, England and Wales, and Finland (AOANJRR 2010, NJR 2011, Cohen 2012, Seppänen et al. 2012). The theoretical health risks related to chronically elevated blood metal ion concentrations induced by abnormal wear and corrosion of the metal-on-metal implants—apart from local symptoms around the failing implant—include systemic symptoms of poisoning (Steens et al. 2006, Oldenburg et al. 2009, Rizzetti et al. 2009, Tower 2010, 2012, Mao et al. 2011, Sotos and Tower 2013, Zyviel et al. 2013) and carcinogenesis (Mäkelä et al. 2012, Smith et al. 2012, Brewster et al. 2013). Systemic metal ion toxicity cases due to a failed hip replacement are rare. However, there have been several recent reports of systemic cobalt toxicity following revision of fractured ceramic components, and also in patients with a failed metal-on-metal hip replacement (Steens et al. 2006, Oldenburg et al. 2009, Rizzetti et al. 2009, Tower 2010, 2012, Mao et al. 2011, Sotos and Tower 2013, Zyviel et al. 2013). Possible clinical findings include fatigue, weakness, hypothyroidism, cardiomyopathy, polycythemia, visual and hearing impairment, cognitive dysfunction, and neuropathy. Fatal cardiomyopathy due to systemic cobalt toxicity after hip replacement has been reported (Zyviel et al. 2013).Metal debris from hip replacement may be associated with chromosomal aberrations and DNA damage (Case et al. 1996, Bonassi et al. 2000, Daley et al. 2004). However, the risk of cancer is not increased after conventional metal-on-polyethylene total hip replacement or after first-generation metal-on-metal total hip arthroplasty (Visuri et al. 1996, 2010a). The short-term overall cancer risk after modern metal-on-metal hip arthroplasty is not increased either (Mäkelä et al. 2012, Smith et al. 2012, Brewster et al. 2013). However, recent linkage studies of overall cancer risk are based on hospital episode statistics, which may have less quality assurance than cancer registry data (Smith et al. 2012, Brewster et al. 2013). Annual updating of cancer registry data concerning the metal-on-metal issue is advisable.In this paper, we update our earlier published results on risk of cancer (Mäkelä et al. 2012) and give an assessment of the overall and cause-specific mortality in primary metal-on-metal and non-metal-on-metal hip replacement patients who were operated on from 2001 to 2010, by combining data from the Finnish Arthroplasty Register, the Population Register Centre, and the Finnish Cancer Registry. The reason for this early updating of the cancer data was to be able to detect a cancerogenic effect of metal-on-metal implants as early as possible.     

Effects of metal-on-metal wear on the host immune system and infection in hip arthroplasty

Background and purpose

Joint replacement with metal-on-metal (MOM) bearings have gained popularity in the last decades in young and active patients. However, the possible effects of MOM wear debris and its corrosion products are still the subject of debate. Alongside the potential disadvantages such as toxicity, the influences of metal particles and metal ions on infection risk are unclear.

Methods

We reviewed the available literature on the influence of degradation products of MOM bearings in total hip arthroplasties on infection risk.

Results

Wear products were found to influence the risk of infection by hampering the immune system, by inhibiting or accelerating bacterial growth, and by a possible antibiotic resistance and heavy metal co-selection mechanism.

Interpretation

Whether or not the combined effects of MOM wear products make MOM bearings less or more prone to infection requires investigation in the near future.Many young patients with painful coxarthrosis want to return to a high level of activity and require an implant that provides durability. The low wear rates of metal-on-metal (MOM) bearings have led to a resurgence in the use of MOM bearings (Wagner and Wagner 2000, Silva et al. 2005, Pollard et al. 2006, Vendittoli et al. 2007, Delaunay et al. 2008). 35% of all prostheses in the United States in 2006 (Bozic et al. 2009) and 16% of all prostheses implanted in Australia from 1999 through 2007 had MOM bearings (Graves et al. 2008).Metal alloys used in MOM bearings degrade through wear, from corrosion, or by a combination of the two (Yan et al. 2006, Jacobs et al. 2008). Consequently, MOM bearings produce nanometer- to submicrometer-sized metal particles (Campbell et al. 1996, Doorn et al. 1998). The high number of these very small particles presents a large cumulative surface area for corrosion. The biological effects of these particles and their corrosion products in the human body are for the most part unclear. Since the renewed interest in MOM bearings, extensive research has been done to determine the consequences of local and systemic exposure to wear particles and accompanying biologically active corrosion products (Amstutz and Grigoris 1996). It is well known that metal debris can induce pathological changes such as the release of inflammatory cytokines from macrophages, histiocytosis, fibrosis, and necrosis (Basle et al. 1996, Granchi et al. 1998, Caicedo et al. 2008, 2009). Metal debris is also thought to be associated with hypersensitivity and osteolysis (Hallab et al. 2000, 2010, Goodman 2007b, Carr and DeSteiger 2008, Huber et al. 2009). However, there is very little literature on the bacteriological effects of these degradation products (Anwar et al. 2007, Hosman et al. 2009). It is therefore unclear whether they can influence the risk of infection.The Australian and New Zealand joint registries have shown that between 9% and 15% of all total hip arthroplasty (THA) revisions are carried out because of infections related to the primary prosthesis (Rothwell et al. 2007, Graves et al. 2008). In cases of infection, bacteria adopt a biofilm mode of growth on the surface of the prosthesis, thus increasing the antibiotic resistance and resulting in major difficulties in treatment (Trampuz and Widmer 2006). Removal and replacement of an infected implant is usually required to eliminate the infection (Bozic and Ries 2005, Vincent et al. 2006). Recent research has suggested that particulate debris of any composition promotes bacterial growth by providing a scaffold for bacterial adhesion and biofilm growth (Anwar et al. 2007). On the other hand, high concentrations of metal ions have been shown to have bacteriostatic properties (Hosman et al. 2009).Considering the paucity of publications on the effects of MOM particles on infection, we performed a review of the literature on the influence of MOM wear particles and their corrosion products on the risk of infection.     

Increased risk of revision of cementless stemmed total hip arthroplasty with metal-on-metal bearings: Data from the Nordic Arthroplasty Register Association

Background and purpose

Data from the national joint registries in Australia and England and Wales have revealed inferior medium-term survivorship for metal-on-metal (MoM) total hip arthroplasty (THA) than for metal-on-polyethylene (MoP) THA. Based on data from the Nordic Arthroplasty Register Association (NARA), we compared the revision risk of cementless stemmed THA with MoM and MoP bearings and we also compared MoM THA to each other.

Patients and methods

We identified 32,678 patients who were operated from 2002 through 2010 with cementless stemmed THA with either MoM bearings (11,567 patients, 35%) or MoP bearings (21,111 patients, 65%). The patients were followed until revision, death, emigration, or the end of the study period (December 31, 2011), and median follow-up was 3.6 (interquartile range (IQR): 2.4–4.8) years for MoM bearings and 3.4 (IQR: 2.0–5.8) years for MoP bearings. Multivariable regression in the presence of competing risk of death was used to assess the relative risk (RR) of revision for any reason (with 95% confidence interval (CI)).

Results

The cumulative incidence of revision at 8 years of follow-up was 7.0% (CI: 6.0–8.1) for MoM bearings and 5.1% (CI: 4.7–5.6) for MoP bearings. At 6 years of follow-up, the RR of revision for any reason was 1.5 (CI: 1.3–1.7) for MoM bearings compared to MoP bearings. The RR of revision for any reason was higher for the ASR (adjusted RR = 6.4, CI: 5.0–8.1), the Conserve Plus (adjusted RR = 1.7, CI: 1.1–2.5) and “other” acetabular components (adjusted RR = 2.4, CI: 1.5–3.9) than for MoP THA at 6 years of follow-up.

Interpretation

At medium-term follow-up, the survivorship for cementless stemmed MoM THA was inferior to that for MoP THA, and metal-related problems may cause higher revision rates for MoM bearings with longer follow-up.Wear particles from the polyethylene liner in metal-on-polyethylene (MoP) bearings in total hip arthroplasty (THA) are associated with osteolysis and aseptic loosening of the implant (Jacobs et al. 1994). Surgeons therefore became interested in alternatives such as metal-on-metal (MoM) bearings. The main justification for using large-diameter-head (LDH) MoM bearings in THA was less wear and the hope of lower revision rates. However, a lower risk of revision has only been found for revision due to dislocation (Kostensalo et al. 2013), whereas the total risk of revision has been found to be increased in some studies (Smith et al. 2012, Huang et al. 2013). In addition, LDH MoM was introduced in order to achieve increased range of motion and better function (Burroughs et al. 2005, Davis et al. 2007), but that has not been shown clinically (Penny et al. 2013).Several concerns about the use of MoM bearings in hip surgery have been voiced in recent years: excessive failure rates for certain brands and implant combinations used with MoM components have been reported (Langton et al. 2011, Australian Orthopaedic Association 2013). Some designs are associated with increased frequency of aseptic loosening (Australian Orthopaedic Association 2013), and large head sizes placed on conventional stems may cause taper junction failure (Langton et al. 2012). Exposure to chromium and cobalt may cause adverse reactions to metal debris (ARMD) (Langton et al. 2010) such as pseudotumors (Pandit et al. 2008) and hypersensivity reactions (Willert et al. 2005) locally in the hip joint. Furthermore, metal ions may be genotoxic (Daley et al. 2004).Only a few population-based studies on MoM bearings in stemmed THAs from hip arthroplasty registries have been published (Smith et al. 2012, Mokka et al. 2013b, Furnes et al. 2014), with only 1 population-based study focusing on causes of revision resulting from specific combinations of acetabular and femoral components (Mokka et al. 2013b). We compared the 6-year revision risk for MoM bearings with that for MoP bearings in cementless stemmed THA. In addition, we studied different designs of stemmed MoM THAs and the causes of revision in a population-based follow-up study using data from the Nordic Arthroplasty Register Association (NARA).     

No clear influence of preference bias on satisfaction and early functional outcome in resurfacing hip arthroplasty

Background and purpose

Hip resurfacing arthroplasty (RHA) is done in patients who often have a high preference for the method. This preference can influence the clinical outcome and satisfaction. We evaluated the potential influence of this preference bias.

Patients and methods

From an ongoing randomized trial comparing RHA with total hip arthroplasty, 28 consecutive patients (28 hips) who had been allocated to an RHA were characterized as the “randomized” group. 22 other patients (24 hips) who had refused participation and had especially requested an RHA were characterized as the “preference” group. Harris hip score (HHS), Oxford hip score (OHS), University of California at Los Angeles activity scale (UCLA), Short Form 12 (SF-12), and visual analog scale satisfaction score (VAS) were assessed in both groups.

Results

Both groups had a high implant satisfaction score (97/100 for the “preference” group and 93/100 for the “randomized” group) at 12 months. The HHS, OHS, and UCLA were similar at baseline and also revealed a similar improvement up to 12 months (p < 0.001). Regarding the SF-12, the “preference” group scored lower on the mental subscale preoperatively (p = 0.03), and there was a greater increase after 12 months (p = 0.03).

Interpretation

We could not show that there was any influence of preference on satisfaction with the implant and early clinical outcome in patients who underwent RHA. The difference in mental subscale scores between groups may still indicate a difference in psychological profile.The outcome of any surgical treatment is influenced by several factors. Apart from the surgical intervention itself, co-morbidities and postoperative rehabilitation—and also factors such as patients'' perception, confidence, and expectations—contribute to the final result and patient satisfaction. Nowadays, most patients have access to the internet and other sources of information, and are well-informed. Their conceptions will lead beliefs and expectations, which will in turn lead to preferences. Preference for a specific treatment can influence the outcome (Torgerson et al. 1996, McPherson et al. 1997, Van der Windt et al 2000, McPherson and Britton 2001, Thomas et al. 2004, Klaber Moffett et al. 2005) and can introduce bias into assessments of satisfaction and acceptability. This might be a confounding factor in a trial, and may affect the validity of the results. To obtain hard evidence of any possible preference effects is problematic, as it is difficult to reliably distinguish between simple therapeutic effects and preference effects mediated through psychological pathways in experiments (McPherson and Chalmers 1998).The dilemma of a possible influence of preference is frequently encountered in studies in orthopedic surgery. For example, the interest in resurfacing hip arthroplasty (RHA) has grown in the past 15 years (National Joint Registry for England and Wales 2004, Chen et al. 2009, National Joint Registry for England and Wales 2009) and has received much international attention. The results reported regarding the short-term and long-term follow-up of RHA appear to correspond with the results of conventional total hip arthroplasty (THA) (Pollard et al. 2006, Vail et al. 2006, Amstutz et al. 2007, Khan et al. 2009, Mont et al. 2009, Lavigne et al. 2010) and the satisfaction rates reported have been 90–100% (Khan et al. 2009, Lingard et al. 2009, Mont et al. 2009). Hip resurfacing surgeons generally deal with patients with a profound preference for this particular implant. We have not found any studies that have incorporated the possible influence of preference of the patient for an RHA into their results, and it can be speculated whether these results are influenced by this preference and perception on the part of the patients.In an ongoing randomized trial comparing RHA with conventional THA, we encountered—as expected—some difficulty in recruiting patients for inclusion, since several patients had a specific demand for RHA. In this way, RHAs were performed in 2 groups of patients: (1) an unbiased “randomized” group without any preferences, willing to participate in the ongoing trial, and simply allocated to RHA; and (2) a “preference” group of “potentially biased” patients with a specific demand for RHA and who declined participation in the trial.We could therefore evaluate the potential role of preference bias on implant satisfaction and early clinical outcome. We hypothesized that patients in the “preference” group would be more satisfied than the patients in the “randomized” group. On the other hand, patients with a high degree of preference could have such high expectations of the treatment that they might be difficult to fulfill, which would lead to lower satisfaction compared to patients without any preference.     

The final follow-up plain radiograph is sufficient for clinical evaluation of polyethylene wear in total hip arthroplasty: A study of validity and reliability

Background and purpose

Radiostereometric analysis (RSA) is a highly accurate tool for assessment of polyethylene (PE) wear in total hip arthroplasty (THA); however, PE wear measurements in clinical studies are often limited to plain radiographs. We evaluated the agreement between PE wear measured with PolyWare software, which uses plain radiographs, and by model-based RSA, which uses stereo radiographs.

Methods

Measurements of PE wear postoperatively and at final follow-up (after mean 6 years) on plain radiographs of 12 patients after cementless THA were evaluated with PolyWare software and the results were compared with those from RSA as the gold standard (Model-based RSA using elementary geometrical shape models; EGS-RSA). With PolyWare, we either used the final radiographic follow-up (PW1) only or both the postoperative follow-up and the final follow-up (PW2).

Results

The 2D mean wear measured (in mm) was 0.80, 1.07, and 0.60 for the PW2, PW1, and RSA method. 2D intra-method repeatability was similar for PW1 and RSA with limits of agreement (LOAs, in mm) of ± 0.22, and ± 0.23, respectively. 2D inter-method concurrent validity was best between PW1 and EGS-RSA with LOAs of ± 0.55. For 2D linear wear measurements, the PW1 method had a clinical repeatability similar to that of RSA.

Interpretation

PW1 is sufficient for retrospective determination of 2D wear from medium-term wear measurements above 0.5 mm, It alleviates the need for baseline plain radiographs, has a clinical precision similar to that of RSA, and is easy and inexpensive to use.Wear of polyethylene (PE) components is widely regarded as the main factor limiting longevity of total hip arthroplasty (THA) (Cooper et al. 1992). Clinical studies have shown that periprosthetic osteolysis and aseptic loosening is strongly related to wear rates of above 0.2 mm/year (Sochart 1999, Dowd et al. 2000).Radiostereometric analysis (RSA) is the most accurate tool for in vivo assessment of PE wear (Kärrholm et al. 1997, von Schewelov et al. 2004, Bragdon et al. 2006), and it is regarded as the gold standard (Ilchmann et al. 1995). However, many radiographic in vivo studies of PE wear in THA are restricted to measurements on plain radiographs because the RSA set-up is expensive and not widely available. Measurement of PE wear on plain radiographs is often limited to 2D analysis because poor quality of cross-table lateral radiographs is a common problem (Sychterz et al. 1999b, 2001). Although PE wear is known to occur multidirectionally (Yamaguchi et al. 1997, Akisue et al. 1999), the bulk of the wear is detectable on the anterior-posterior radiographs alone (Sychterz et al. 1997, Hui et al. 2003, Martell et al. 2003). Based on the availability of radiographs and investigator preferences, some authors favor analysis of serial radiographs (Sychterz et al. 1997, Kim et al. 2001, Hernigou and Bahrami 2003) to describe the pattern of wear and the steady-state wear (Sychterz et al. 1999a, Bragdon et al. 2006), whereas others use 2 radiographic follow-ups (postoperative and latest) (Kraay et al. 2006), or only the latest radiographic follow-up with the assumption of zero wear at baseline (Norton et al. 2002)Little is known about the conformity between PE wear results measured with RSA and computerized methods using plain radiographs (Ilchmann et al. 1995, von Schewelov et al. 2004, Bragdon et al. 2006). Our group has questioned the conformity of 2D PE wear measurements based on serial, 2, or 1 radiographic follow-up (Stilling et al. 2009b). We determined that there was a statistically significant difference between all approaches, but we were unable to determine which strategy best reflected the true extent of wear (Stilling et al. 2009b). In addition, we recently showed that model-based RSA is an accurate tool for measurement of PE wear in good agreement with the true wear (Stilling 2009).We have now studied the intra-method repeatability and concurrent validity between 2 methods (PolyWare and EGS-RSA) for measurement of PE wear in THA, in a group of patients with an average follow-up of 6 years. We wanted to determine (1) whether there would be a difference in repeatability between the methods, (2) whether there would be a difference in wear measured using 1 or 2 radiographic follow-ups with the PolyWare method, and (3) whether either of the 2 PolyWare measurement strategies (1 or 2 radiographic follow-ups) would give results similar to the wear measured by RSA (concurrent validity).     

Locking plate osteosynthesis in displaced 4-part fractures of the proximal humerus

Background and purpose

There is considerable uncertainty about the optimal treatment of displaced 4-part fractures of the proximal humerus. Within the last decade, locking plate technology has been considered a breakthrough in the treatment of these complex injuries.

Methods

We systematically identified and reviewed clinical studies on the benefits and harms after osteosynthesis with locking plates in displaced 4-part fractures.

Results

We included 14 studies with 374 four-part fractures. There were 10 case series, 3 retrospective observational comparative studies, 1 prospective observational comparative study, and no randomized trials. Small studies with a high risk of bias precluded reliable estimates of functional outcome. High rates of complications (16–64%) and reoperations (11–27%) were reported.

Interpretation

The empirical foundation for the value of locking plates in displaced 4-part fractures of the proximal humerus is weak. We emphasize the need for well-conducted randomized trials and observational studies.There is considerable uncertainty about the optimal treatment of displaced 4-part fractures of the proximal humerus (Misra et al. 2001, Handoll et al. 2003, Bhandari et al. 2004, Lanting et al. 2008). Only 2 small inconclusive randomized trials have been published (Stableforth 1984, Hoellen et al. 1997). A large number of interventions are used routinely, ranging from a non-operative approach to open reduction and internal fixation (ORIF), and primary hemiarthroplasty (HA).In the last decade, locking plate technology has been developed and has been heralded as a breakthrough in the treatment of fractures in osteoporotic bone (Gautier and Sommer 2003, Sommer et al. 2003, Haidukewych 2004, Miranda 2007). Locking plate technique is based on the elimination of friction between the plate and cortex, and relies on stability between the subchondral bone and screws. Multiple multidirectional convergent and divergent locking screws enhance the angular stability of the osteosynthesis, possibly resulting in better postoperative function with reduced pain. Reported complications include screw cut-out, varus fracture collapse, tuberosity re-displacement, humeral head necrosis, plate impingement, and plate or screw breakage (Hall et al. 2006, Tolat et al. 2006, van Rooyen et al. 2006, Agudelo et al. 2007, Gardner et al. 2007, Khunda et al. 2007, Ring 2007, Smith et al. 2007, Voigt et al. 2007, Egol et al. 2008, Kirchhoff et al. 2008, Owsley and Gorczyca 2008, Brunner et al. 2009, Micic et al. 2009, Sudkamp et al. 2009). The balance between the benefit and harms of the intervention seems delicate.Several authors of narrative reviews and clinical series have strongly recommended fixation of displaced 4-part fractures of the humerus with locking plates (Bjorkenheim et al. 2004, Hente et al. 2004, Hessler et al. 2006, Koukakis et al. 2006, Kilic et al. 2008, Korkmaz et al. 2008, Shahid et al. 2008, Papadopoulos et al. 2009, Ricchetti et al. 2009) and producers of implants unsurprisingly strongly advocate them (aap Implantate 2010, Stryker 2010, Synthes 2010, Zimmer 2010). Despite the increasing use of locking plates (Illert et al. 2008, Ricchetti et al. 2009), we have been unable to identify systematic reviews on the benefits and harms of this new technology in displaced 4-part fractures. Thus, we systematically identified and reviewed clinical studies on the benefits and harms after osteosynthesis with locking plates in displaced 4-part fractures of the proximal humerus.     

Hospital volume affects outcome after total knee arthroplasty: A nationwide registry analysis of 80 hospitals and 59,696 replacements

ResultsThe greater the volume of the hospital, the shorter was the average LOS and LUIC. Smaller hospital volume was not unambiguously associated with increased revision, re-admission, or MUA rates. The smaller the annual hospital volume, the more often patients were discharged home.InterpretationLOS and LUIC ought to be shortened in lower-volume hospitals. There is potential for a reduction in length of stay in extended institutional care facilities.Total knee replacement (TKR) is one of the most common orthopedic procedures, and it is expected to increase markedly in volume (Kurtz et al. 2007). Due to the potentially severe complications and the high economic impact of the procedure, efforts to minimize the risks and optimize perioperative efficiency are important.It has been suggested that increased hospital volume and reduction in length of stay (LOS) at the operating hospital after TKR are related, but there is no consensus (Yasunaga et al. 2009, Marlow et al. 2010, Paterson et al. 2010, Bozic et al. 2010, Styron et al. 2011). In addition, results on the association of hospital volume with re-admission rates (Soohoo et al. 2006b, Judge et al. 2006, Bozic et al. 2010, Cram et al. 2011) and revision risk have been inconclusive (Shervin et al. 2007, Manley et al. 2009, Bozic et al. 2010, Paterson et al. 2010). No-one has tried to study the association between length of uninterrupted institutional care (LUIC), incidence of manipulation under anesthesia (MUA) after TKR, and hospital volume.By combining 5 national-level registries, we examined possible associations between hospital volume and LOS, LUIC, discharge disposition, number of re-admissions within 14 and 42 days, MUA, and revisions after TKR for all knee arthroplasties performed in Finland between 1998 and 2010.     

Hip resurfacing arthroplasty: short-term survivorship of 4,401 hips from the Finnish Arthroplasty Register

Background and purpose

Population-based registry data from the Nordic Arthroplasty Register Association (NARA) and from the National Joint Register of England and Wales have revealed that the outcome after hip resurfacing arthroplasty (HRA) is inferior to that of conventional total hip arthroplasty (THA). We analyzed the short-term survival of 4,401 HRAs in the Finnish Arthroplasty Register.

Methods

We compared the revision risk of the 4,401 HRAs from the Register to that of 48,409 THAs performed during the same time period. The median follow-up time was 3.5 (0–9) years for HRAs and 3.9 (0–9) years for THAs.

Results

There was no statistically significant difference in revision risk between HRAs and THAs (RR = 0.93, 95% CI: 0.78–1.10). Female patients had about double the revision risk of male patients (RR = 2.0, CI: 1.4–2.7). Hospitals that had performed 100 or more HRA procedures had a lower revision risk than those with less than 100 HRAs (RR = 0.6, CI: 0.4–0.9). Articular Surface Replacement (ASR, DePuy) had inferior outcome with higher revision risk than the Birmingham Hip Resurfacing implant (BHR, Smith & Nephew), the reference implant (RR = 1.8, CI: 1.2–2.7).

Interpretation

We found that HRA had comparable short-term survivorship to THA at a nationwide level. Implant design had an influence on revision rates. ASR had higher revision risk. Low hospital procedure volume worsened the outcome of HRA. Female patients had twice the revision risk of male patients.Good short-term results of using modern hip resurfacing devices have been reported from pioneering centers (Amstutz et al. 2004, Daniel et al. 2004). Recently, these results have been confirmed by independent studies (Hing et al. 2007a, Heilpern et al. 2008, Steffen et al. 2008, Khan et al. 2009). However, there have been a variety of early complications of HRA, such as femoral neck fracture, aseptic loosening of the femoral component, and metallosis of the hip joint with soft-tissue necrosis (Shimmin et al. 2005, Keegan et al. 2007, Grammatopolous et al. 2009, Ollivere et al. 2009). Registry data have revealed that the early revision rate of HRA is higher than that of THA (Australian Orthopaedic Association, Johanson et al. 2010). Furthermore, conventional stems can nowadays be used with a large metal-on-metal (MoM) articulation similar to that in HRA. We examined the early outcome of HRA and compared it to that of THA using data in the Finnish Arthroplasty Register.     

Body mass index and risk of perioperative cardiovascular adverse events and mortality in 34,744 Danish patients undergoing hip or knee replacement

Background and purpose

Obesity is a risk factor for osteoarthritis in the lower limb, yet the cardiovascular risks associated with obesity in hip or knee replacement surgery are unknown. We examined associations between body mass index (BMI) and the risk of a major adverse cardiovascular event (MACE: ischemic stroke, acute myocardial infarction, or cardiovascular death) or the risk of all-cause mortality in a nationwide Danish cohort of patients who underwent primary hip or knee replacement surgery.

Methods

Using Danish nationwide registries, we identified 34,744 patients aged ≥ 20 years who underwent elective primary hip or knee replacement surgery between 2005 and 2011. We used multivariable Cox regression models to calculate the 30-day risks of MACE and mortality associated with 5 BMI groups (underweight (BMI < 18.5 kg/m²), normal weight (18.5–24 kg/m²), overweight (25–29 kg/m²), obese 1 (30–34 kg/m²), and obese 2 (≥ 35 kg/m²)).

Results

In total, 232 patients (0.7%) had a MACE and 111 (0.3%) died. Compared with overweight, adjusted hazard ratios (HRs) were 1.2 (95% CI: 0.4–3.3), 1.3 (0.95–1.8), 1.6 (1.1–2.2), and 1.0 (0.6–1.9) for underweight, normal weight, obese 1, and obese 2 regarding MACE. Regarding mortality, the corresponding HRs were 7.0 (2.8–15), 2.0 (1.2–3.2), 1.5 (0.9–2.7), and 1.9 (0.9–4.2). Cubic splines suggested a significant U-shaped relationship between BMI and risks with nadir around 27–28.

Interpretation

In an unselected cohort of patients undergoing elective primary hip or knee replacement surgery, U-shaped risks of perioperative MACE and mortality were found in relation to BMI. Patients within the extreme ranges of BMI may warrant further attention.Obesity is one of the most prominent risk factors for the development and progression of osteoarthritis in the lower limb, especially in the knee (Felson et al. 1988, Sturmer et al. 2000). As a result, overweight people are overrepresented among patients undergoing joint replacement surgery (Bostman 1994, Cooper et al. 1998, Karlson et al. 2003, Jain et al. 2005). With an increasing proportion of elderly people and the high prevalence of overweight/obesity in the general population, the demand for joint replacement surgery is expected to rise (Kurtz et al. 2007). Considerable risks of peroperative and postoperative complications have been reported for obese patients undergoing hip or knee replacement surgery (Winiarsky et al. 1998, Foran et al. 2004a, Schwarzkopf et al. 2012), although with conflicting results (Pritchett and Bortel 1991, Griffin et al. 1998, Hawker et al. 1998, Winiarsky et al. 1998, Spicer et al. 2001, Foran et al. 2004a, b, Flegal et al. 2005, Davis et al. 2011). The majority of previous studies have focused on orthopedic-related outcomes, e.g. risks of infection and prosthesis dislocation (Smith et al. 1992, Griffin et al. 1998, Deshmukh et al. 2002, Amin et al. 2006, Hamoui et al. 2006). Major surgical procedures, including joint replacement surgery, also carry a significant risk of adverse cardiovascular events and mortality. Previous research has suggested that obesity may increase perioperative cardiovascular and mortality risks, but it has not concentrated specifically on elective hip and knee replacement surgery (Bamgbade et al. 2007). We therefore evaluated the relationship between body mass index (BMI) and perioperative cardiovascular events and mortality, as well as 1-year mortality, in patients undergoing elective total hip or knee replacement in a nationwide setting. We hypothesized that obese patients would have higher risk of adverse cardiovascular events than patients who were not obese.     

Is the transverse acetabular ligament a reliable cup orientation guide?: Computer simulation in 160 hips

Background and purpose

It is controversial whether the transverse acetabular ligament (TAL) is a reliable guide for determining the cup orientation during total hip arthroplasty (THA). We investigated the variations in TAL anatomy and the TAL-guided cup orientation.

Methods

80 hips with osteoarthritis secondary to hip dysplasia (OA) and 80 hips with osteonecrosis of the femoral head (ON) were examined. We compared the anatomical anteversion of TAL and the TAL-guided cup orientation in relation to both disease and gender using 3D reconstruction of computed tomography (CT) images.

Results

Mean TAL anteversion was 11° (SD 10, range –12 to 35). The OA group (least-square mean 16°, 95% confidence interval (CI): 14–18) had larger anteversion than the ON group (least-square mean 6.2°, CI: 3.8 – 7.5). Females (least-square mean 20°, CI: 17–23) had larger anteversion than males (least-square mean 7.0°, CI: 4.6–9.3) in the OA group, while there were no differences between the sexes in the ON group. When TAL was used for anteversion guidance with the radiographic cup inclination fixed at 40°, 39% of OA hips and 9% of ON hips had more than 10° variance from the target anteversion, which was 15°.

Interpretation

In ON hips, TAL is a good guide for determining cup orientation during THA, although it is not a reliable guide in hips with OA secondary to dysplasia. This is because TAL orientation has large individual variation and is influenced by disease and gender.Malalignment of the acetabular cup may lead to dislocation (Jolles et al. 2002, Shon et al. 2005), accelerated wear or breakage of the bearing, and component loosening (Kennedy et al. 1998). The use of a mechanical guide for cup implantation may give inaccurate results because of pelvic rotation on the operating table (Sugano et al. 2007, Minoda et al. 2010).Recently, the transverse acetabular ligament (TAL), which bridges the acetabular notch (Löhe et al. 1996) as part of the acetabular labrum, has been reported to be useful for determining proper orientation of the acetabular components (Archbold et al. 2006, 2008, Pearce et al. 2008, Kalteis et al. 2011). TAL-guided cup orientation has been reported to guide the cup placement within Lewinnek’s safe zone (Lewinnek et al. 1978). Other studies have shown that the TAL is not a reliable guide (Epstein et al. 2010, Viste et al. 2011). We hypothesized that these divergent results could be explained by individual anatomical variation; in addition, orientation of the TAL may be affected by hip disease and gender. Furthermore, cup orientation is influenced by sagittal pelvic tilt (Nishihara et al. 2003, DiGioia et al. 2006).We determined (1) the variation in the TAL orientation and the influence of hip disease and gender on this variation, (2) the reliability of using the TAL for guiding cup orientation, and (3) the influence of pelvic tilt on the TAL-guided cup orientation, using computed tomography (CT) scan and computer simulation.     

Patient-reported outcome and risk of revision after shoulder replacement for osteoarthritis: 1,209 cases from the Danish Shoulder Arthroplasty Registry, 2006–2010

Purpose

We used patient-reported outcome and risk of revision to compare hemiarthroplasty (HA) with total shoulder arthroplasty (TSA) and stemmed hemiarthroplasty (SHA) with resurfacing hemiarthroplasty (RHA) in patients with glenohumeral osteoarthritis.

Patients and methods

We included all patients reported to the Danish Shoulder Arthroplasty Registry (DSR) between January 2006 and December 2010. 1,209 arthroplasties in 1,109 patients were eligible. Western Ontario Osteoarthritis of the Shoulder index (WOOS) was used to evaluate patient-reported outcome 1 year postoperatively. For simplicity of presentation, the raw scores were converted to a percentage of the maximum score. Revision rates were calculated by checking reported revisions to the DSR until December 2011. WOOS and risk of revision were adjusted for age, sex, previous surgery, and type of osteoarthritis.

Results

There were 113 TSAs and 1096 HAs (837 RHAs and 259 SHAs). Patients treated with TSA generally had a better WOOS, exceeding the predefined minimal clinically important difference, at 1 year (mean difference 10, p < 0.001). RHA had a better WOOS than SHA (mean difference 5, p = 0.02), but the difference did not exceed the minimal clinically important difference. There were no statistically significant differences in revision rate or in adjusted risk of revision between any of the groups.

Interpretation

Our results are in accordance with the results from other national shoulder registries and the results published in systematic reviews favoring TSA in the treatment of glenohumeral osteoarthritis. Nonetheless, this registry study had certain limitations and the results should be interpreted carefully.Stemmed hemiarthroplasty (SHA), which evolved from the early monoblock design of Charles Neer (1917–2011), is still used in the treatment of glenohumeral osteoarthritis. The original design has been modified to a modular prosthesis with the head connected to the stem by a taper locking system. The results have been reported in numerous studies, showing substantial pain relief and improved function (Gartsman et al. 2000, Norris and Iannotti 2002, Edwards et al. 2003, Lo et al. 2005, Haines et al. 2006, Radnay et al. 2007). Nonetheless, some patients fail to benefit from the operation, which may be due to glenoid wear (Parsons et al. 2004). Total shoulder arthroplasty (TSA) may be the preferred treatment due to a superior functional outcome, but the risk of glenoid loosening has been worrying (Bishop and Flatow 2005, Bryant et al. 2005, Radnay et al. 2007, Singh et al. 2011).The first resurfacing hemiarthroplasty (RHA) to be used in a greater numbers was the SCAN (Scandinavian) Cup, which was introduced in 1981 for the treatment of rheumatoid arthritis (Jonsson et al. 1986). A few years later, the concept was applied to other diagnoses including osteoarthritis (Levy and Copeland 2001). The modern hydroxyapatite-coated resurfacing arthroplasty, which is still used today, was introduced in 1993 (Levy and Copeland 2004). Even so, despite the long-term use of RHA the functional outcome and risk of revision have only been reported in small case series (Levy and Copeland 2004, Bailie et al. 2008, Al-Hadithy et al. 2012, Mansat et al. 2013).In this study, we used patient-reported outcome and risk of revision to compare hemiarthroplasty (HA) and TSA in patients diagnosed with glenohumeral osteoarthritis, and also to compare SHA and RHA.     

Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty. Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007

Background and purpose

The reported outcomes of hip resurfacing arthroplasty (HRA) vary. The frequency of this procedure in Denmark, Norway, and Sweden is low. We therefore determined the outcome of HRA in the NARA database, which is common to all 3 countries, and compared it to the outcome of conventional total hip arthroplasty (THA).

Methods

The risk of non-septic revision within 2 years was analyzed in 1,638 HRAs and compared to that for 172,554 conventional total hip arthroplasties (THAs), using Cox regression models. We calculated relative risk (RR) of revision and 95% confidence interval.

Results

HRA had an almost 3-fold increased revision risk compared to THA (RR = 2.7, 95% CI: 1.9–3.7). The difference was even greater when HRA was compared to the THA subgroup of cemented THAs (RR = 3.8, CI: 2.7–5.3). For men below 50 years of age, this difference was less pronounced (HRA vs. THA: RR = 1.9, CI: 1.0–3.9; HRA vs. cemented THA: RR = 2.4, CI: 1.1–5.3), but it was even more pronounced in women of the same age group (HRA vs. THA: RR = 4.7, CI: 2.6–8.5; HRA vs. cemented THA: RR = 7.4, CI: 3.7–15). Within the HRA group, risk of non-septic revision was reduced in hospitals performing ≥ 70 HRAs annually (RR = 0.3, CI: 0.1–0.7) and with use of Birmingham hip resurfacing (BHR) rather than the other designs as a group (RR = 0.3, CI: 0.1–0.7). Risk of early revision was also reduced in males (RR = 0.5, CI: 0.2–0.9). The femoral head diameter alone had no statistically significant influence on the early revision rate, but it eliminated the significance of male sex in a combined analysis.

Interpretation

In general, our results do not support continued use of hip resurfacing arthroplasty. Men had a lower early revision rate, which was still higher than observed for all-cemented hips. Further follow-up is necessary to determine whether HRA might be useful as an alternative in males.The development of contemporary metal-on-metal (MOM) bearings has stimulated renewed interest in hip resurfacing arthroplasty (HRA) of the hip. These devices are available in different designs, most of which are hybrid concepts with cemented femoral and uncemented acetabular components. The proposed advantages of HRA compared to conventional total hip arthroplasty (THA) include improved range of motion and hip function, bone preservation, lower dislocation rates, and easier and safer revision procedures in case of failure (Shimmin et al. 2008). Because of the low wear characteristics observed in the laboratory and in clinical situations, the MOM bearing is thought to be especially suitable for patients with a long life expectancy (McMinn and Daniel 2006).Early reports from specialized centers have shown high survival rates: 97.8–99.8% after 3–5 years (Daniel et al. 2004, Treacy et al. 2005, Hing et al. 2007). Other authors have reported inferior results (Kim et al. 2008, Stulberg et al. 2008). Narrowing of patient selection criteria and refinement of surgical technique have improved the results in some case series (Mont et al. 2007, Amstutz et al. 2007). Several studies have shown that HRA is associated with a long learning curve. Early failures or inadequate implant positioning occurred at the beginning of the learner''s case series, which tended to decrease thereafter (Marker et al. 2007, Witjes et al. 2009, Nunley et al. 2010). Early failures are most commonly caused by femoral neck fracture and aseptic loosening of the femoral component. Thus, there are several indications that the outcome of HRA is influenced by patient selection, surgical technique, and experience in using this type of implant.Short- and medium-term results of HRA have previously been reported from national joint replacement registries. There has been a rapid increase in the use of HRA, with varying percentages of HRA relative to the total volume of THAs reported by different registries (Kärrholm et al. 2008, CJRR 2008-2009, AOANJRR 2008). Reports of inferior results, except in younger males with primary osteoarthritis, are most probably responsible for the recent tendency of decreasing use of HRA—especially in females (AOANJRR 2008). Further reports of comparatively rare but serious complications (Pandit et al. 2008, Hart et al. 2009, Ollivere et al. 2009) have probably also contributed to this tendency. Poor results after revision of failed HRA, equal to those obtained after revision of THA (AOANJRR 2008), may also have contributed to more restricted use.We analyzed the early outcome concerning aseptic revisions within 2 years of HRA and compared it to that of THA in the common database of the Nordic Arthroplasty Register Association (Havelin et al. 2009). We also evaluated the extent to which outcome was influenced by implant design, number of procedures per hospital, and femoral head size.     

Metal release and metal allergy after total hip replacement with resurfacing versus conventional hybrid prosthesis: 5-year follow-up of 52 patients

Background

Metal-on-metal (MOM) total hip arthroplasties were reintroduced because of the problems with osteolysis and aseptic loosening related to polyethylene wear of early metal-on-polyethylene (MOP) arthroplasties. The volumetric wear rate has been greatly reduced with MOM arthroplasties; however, because of nano-size wear particles, the absolute number has been greatly increased. Thus, a source of metal ion exposure with the potential to sensitize patients is present. We hypothesized that higher amounts of wear particles result in increased release of metal ions and ultimately lead to an increased incidence of metal allergy.

Methods

52 hips in 52 patients (median age 60 (51–64) years, 30 women) were randomized to either a MOM hip resurfacing system (ReCap) or a standard MOP total hip arthoplasty (Mallory Head/Exeter). Spot urine samples were collected preoperatively, postoperatively, after 3 months, and after 1, 2, and 5 years and tested with inductively coupled plasma-sector field mass spectrometry. After 5 years, hypersensitivity to metals was evaluated by patch testing and lymphocyte transformation assay. In addition, the patients answered a questionnaire about hypersensitivity.

Results

A statistically significant 10- to 20-fold increase in urinary levels of cobalt and chromium was observed throughout the entire follow-up in the MOM group. The prevalence of metal allergy was similar between groups.

Interpretation

While we observed significantly increased levels of metal ions in the urine during the entire follow-up period, no difference in prevalence of metal allergy was observed in the MOM group. However, the effect of long-term metal exposure remains uncertain.In the 1960s and 1970s, the articulations of hip implants were mainly metal-on-metal (MOM). The implants released cobalt, chromium, and nickel, which could be found in high levels in the blood, hair, and urine (Coleman et al. 1973, Benson et al. 1975, Elves et al. 1975, Gawkrodger 2003). Furthermore, the patients became sensitized to the metals released and an association with early loosening was observed (Coleman et al. 1973, Benson et al. 1975, Elves et al. 1975, Gawkrodger 2003, Jacobs et al. 2009). Gradually, MOM implants were abandoned and the work by Sir John Charley with the metal-on-polyethylene (MOP) bearing advanced hip replacement substantially. However, the MOM articulation was reintroduced in the 1990s, as it became clear that polyethylene debris caused osteolysis, which was a significant clinical issue—especially in young and active patients (Marshall et al. 2008). The MOM Hip Resurfacing System has been proposed to have advantages such as enhanced longevity (Chan et al. 1999, Sieber et al. 1999, Firkins et al. 2001), enhanced implant fixation (Grigoris et al. 2006), lower dislocation rate (Scifert et al. 1998), better reproduction of hip mechanics, and more native femoral shaft bone stock left for revision surgery (Shimmin et al. 2008).MOM articulations have greatly reduced the volumetric wear rate of hip prostheses; however, because of nano-sized metal wear particles, the absolute number of wear particles has greatly increased (Doorn et al. 1998, Chan et al. 1999, Sieber et al. 1999, Firkins et al. 2001, Rieker and Kottig. 2002). Also, Hallab et al. (2004) suggested that the prevalence of metal allergy could be higher in patients with implant failure. In both cases, a source of metal ion exposure with the potential to sensitize patients is present, but the long-term biological effect of the metal wear debris remains unknown.Metal hypersensitivity is a well-established phenomenon and is common, affecting about 10–15% of the general population (Thyssen and Menne 2010). Metal allergy can develop after prolonged or repeated cutaneous exposure to metal, usually from consumer products. Affected individuals typically suffer from allergic contact dermatitis and react with cutaneous erythema, papules, and vesicles after skin contact. This reaction is categorized as a type-4 T-cell-mediated hypersensitivity reaction. Also, metal hypersensitivity may develop following internal exposure to metal-releasing implants. Theoretically, metal hypersensitivity could lead to a powerful reaction to prosthesis implantation (Pandit et al. 2008).We hypothesized that an increased number of wear particles from MOM hip resurfacing arthroplasty (HRA) would lead to increased blood levels and urinary excretion of metal ions, and ultimately to an increased prevalence of metal allergy.